Literature DB >> 24379600

Smoking, alcohol consumption, and the risk of extrahepatic cholangiocarcinoma: a meta-analysis.

Xiao-Hua Ye1, Jia-Ping Huai1, Jin Ding1, Yan-Ping Chen1, Xue-Cheng Sun1.   

Abstract

AIM: To assess the association between smoking and alcohol consumption and extrahepatic cholangiocarcinoma (ECC) through a meta-analysis of clinical observational studies.
METHODS: A literature search was conducted using Embase and MEDLINE databases from inception to 31 May 2013 without language limitations, and by manually searching the references of retrieved articles. Case-control and cohort studies that investigated the association between smoking or alcohol consumption and ECC were included. The quality of these studies was assessed using the Newcastle-Ottawa quality assessment scale. Summary relative risks and corresponding 95%CI were calculated using a random-effects model. Publication bias was assessed by Begg's funnel plot and Egger's test.
RESULTS: A total of 12 eligible articles (11 case-control studies and one cohort study) were included in this meta-analysis. Eleven studies reported the association between smoking and ECC. Pooled analysis indicated that smokers had an increased risk of ECC development as compared with non-smokers (summary RR = 1.23; 95%CI: 1.01-1.50). This correlation was present in population-based studies (n = 5; summary RR = 1.47; 95%CI: 1.06-2.05) but not in hospital-based studies (n = 6; summary RR = 1.10; 95%CI: 0.88-1.37) and in non-Asian regions (n = 7; summary RR = 1.39; 95%CI: 1.03-1.87) but not in Asia (n = 4; summary RR = 1.08; 95%CI: 0.85-1.38). Seven studies reported an association between consuming alcohol and ECC. Pooled analysis indicated that alcohol drinkers had a similar risk of ECC development as did individuals who did not drink alcohol (summary RR = 1.09; 95%CI: 0.87-1.37). There was moderate heterogeneity among the studies and no evidence of publication bias.
CONCLUSION: Smoking is associated with an increased risk of ECC, but alcohol consumption is not. Further population-based studies, particularly cohort studies, are warranted to enable definitive conclusions.

Entities:  

Keywords:  Alcohol consumption; Extrahepatic cholangiocarcinoma; Meta-analysis; Relative risk; Smoking

Mesh:

Year:  2013        PMID: 24379600      PMCID: PMC3870528          DOI: 10.3748/wjg.v19.i46.8780

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  40 in total

1.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

2.  Operating characteristics of a rank correlation test for publication bias.

Authors:  C B Begg; M Mazumdar
Journal:  Biometrics       Date:  1994-12       Impact factor: 2.571

3.  A population-based case-control study of cancer of the bile ducts and gallbladder in Quebec, Canada.

Authors:  P Ghadirian; A Simard; J Baillargeon
Journal:  Rev Epidemiol Sante Publique       Date:  1993       Impact factor: 1.019

4.  Descriptive epidemiology of cholangiocarcinoma in Italy.

Authors:  Domenico Alvaro; Emanuele Crocetti; Stefano Ferretti; Maria Consiglia Bragazzi; Riccardo Capocaccia
Journal:  Dig Liver Dis       Date:  2009-12-22       Impact factor: 4.088

5.  Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veterans.

Authors:  Hashem B El-Serag; Eric A Engels; Ola Landgren; Elizabeth Chiao; Louise Henderson; Harshinie C Amaratunge; Thomas P Giordano
Journal:  Hepatology       Date:  2009-01       Impact factor: 17.425

Review 6.  Cholangiocarcinoma: lessons from Thailand.

Authors:  Banchob Sripa; Chawalit Pairojkul
Journal:  Curr Opin Gastroenterol       Date:  2008-05       Impact factor: 3.287

7.  Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study.

Authors:  Tania M Welzel; Barry I Graubard; Hashem B El-Serag; Yasser H Shaib; Ann W Hsing; Jessica A Davila; Katherine A McGlynn
Journal:  Clin Gastroenterol Hepatol       Date:  2007-08-06       Impact factor: 11.382

8.  Smoking, alcohol consumption and the risk of cancer of the biliary tract; a population-based case-control study in The Netherlands.

Authors:  C J Moerman; H B Bueno de Mesquita; S Runia
Journal:  Eur J Cancer Prev       Date:  1994-09       Impact factor: 2.497

9.  Does quality of observational studies affect the results of a meta-analysis?: the case of cigarette smoking and pancreatic cancer.

Authors:  Giuseppe La Torre; Chiara de Waure; Maria Lucia Specchia; Nicola Nicolotti; Silvio Capizzi; Antonella Bilotta; Gennaro Clemente; Walter Ricciardi
Journal:  Pancreas       Date:  2009-04       Impact factor: 3.327

10.  Rising trends in cholangiocarcinoma: is the ICD classification system misleading us?

Authors:  Shahid A Khan; Shireen Emadossadaty; Nimzing G Ladep; Howard C Thomas; Paul Elliott; Simon D Taylor-Robinson; Mireille B Toledano
Journal:  J Hepatol       Date:  2011-12-13       Impact factor: 25.083

View more
  13 in total

1.  Smoking, Alcohol, and Biliary Tract Cancer Risk: A Pooling Project of 26 Prospective Studies.

Authors:  Emma E McGee; Sarah S Jackson; Jessica L Petrick; Alison L Van Dyke; Hans-Olov Adami; Demetrius Albanes; Gabriella Andreotti; Laura E Beane-Freeman; Amy Berrington de Gonzalez; Julie E Buring; Andrew T Chan; Yu Chen; Gary E Fraser; Neal D Freedman; Yu-Tang Gao; Susan M Gapstur; J Michael Gaziano; Graham G Giles; Eric J Grant; Francine Grodstein; Patricia Hartge; Mazda Jenab; Cari M Kitahara; Synnove F Knutsen; Woon-Puay Koh; Susanna C Larsson; I-Min Lee; Linda M Liao; Juhua Luo; Roger L Milne; Kristine R Monroe; Marian L Neuhouser; Katie M O'Brien; Ulrike Peters; Jenny N Poynter; Mark P Purdue; Kim Robien; Dale P Sandler; Norie Sawada; Catherine Schairer; Howard D Sesso; Tracey G Simon; Rashmi Sinha; Rachael Stolzenberg-Solomon; Shoichiro Tsugane; Renwei Wang; Elisabete Weiderpass; Stephanie J Weinstein; Emily White; Alicja Wolk; Jian-Min Yuan; Anne Zeleniuch-Jacquotte; Xuehong Zhang; Bin Zhu; Katherine A McGlynn; Peter T Campbell; Jill Koshiol
Journal:  J Natl Cancer Inst       Date:  2019-12-01       Impact factor: 13.506

Review 2.  The treatment of cholangiocarcinoma: a hepatologist's perspective.

Authors:  Kamran Qureshi; Randhir Jesudoss; Abdullah M S Al-Osaimi
Journal:  Curr Gastroenterol Rep       Date:  2014-10

3.  Expression and prognostic value of glutamate dehydrogenase in extrahepatic cholangiocarcinoma patients.

Authors:  Zheng Su; Gaojie Liu; Tingfeng Fang; Ketao Zhang; Shanglin Yang; Huayao Zhang; Yang Wang; Zejian Lv; Jianping Liu
Journal:  Am J Transl Res       Date:  2017-05-15       Impact factor: 4.060

Review 4.  The diagnosis and treatment of cholangiocarcinoma.

Authors:  Arndt Vogel; Henning Wege; Karel Caca; Björn Nashan; Ulf Neumann
Journal:  Dtsch Arztebl Int       Date:  2014-10-31       Impact factor: 5.594

5.  Underexpression of miR-126-3p in Patients with Cholangiocarcinoma.

Authors:  Lucas Poleto Spinola; Gabriel F Vieira; Rafael Fernandes Ferreira; Maria C J Calastri; Graciele D Tenani; Franciana L Aguiar; Ilka F Santana Ferreira Boin; Larissa B E Da Costa; Maria Fernanda Chaim Correia; Eliane M Zanovelo; Daniele C B De Souza; Rita C Martins Alves Da Silva; Renato Ferreira Da Silva; Ana Margarida Coelho Abrantes; Maria Filomena R R Botelho; Jose Guilherme L R Tralhão; Doroteia R S Souza
Journal:  Asian Pac J Cancer Prev       Date:  2021-02-01

Review 6.  Risk Factors for Cholangiocarcinoma in Thailand: A Systematiczzm321990Review and Meta-Analysis

Authors:  Siriporn Kamsa-ard; Supot Kamsa-ard; Vor Luvira; Krittika Suwanrungruang; Patravoot Vatanasapt; Surapon Wiangnon
Journal:  Asian Pac J Cancer Prev       Date:  2018-03-27

7.  Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: A population-based study in SEER-Medicare.

Authors:  Jessica L Petrick; Baiyu Yang; Sean F Altekruse; Alison L Van Dyke; Jill Koshiol; Barry I Graubard; Katherine A McGlynn
Journal:  PLoS One       Date:  2017-10-19       Impact factor: 3.240

Review 8.  Molecular Pathogenesis of Cholangiocarcinoma.

Authors:  Peter L Labib; George Goodchild; Stephen P Pereira
Journal:  BMC Cancer       Date:  2019-02-28       Impact factor: 4.430

Review 9.  Liquid biopsy in cholangiocarcinoma: Current status and future perspectives.

Authors:  Gianluca Rompianesi; Marcello Di Martino; Alex Gordon-Weeks; Roberto Montalti; Roberto Troisi
Journal:  World J Gastrointest Oncol       Date:  2021-05-15

10.  Smoking, Alcohol Consumption, and Risks for Biliary Tract Cancer and Intrahepatic Bile Duct Cancer.

Authors:  Takeshi Makiuchi; Tomotaka Sobue; Tetsuhisa Kitamura; Norie Sawada; Motoki Iwasaki; Taiki Yamaji; Taichi Shimazu; Manami Inoue; Shoichiro Tsugane
Journal:  J Epidemiol       Date:  2018-05-11       Impact factor: 3.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.